Kim Mina
Insider CIK 1668163 · RUN General Counsel · ATRA Senior VP & General Counsel · ZY Chief Legal Officer · SLRN Chief Legal & Admin. Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 362,719 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 85,226 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 1,195,856 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 190,114 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer | 2025-05-21 | 2025-05-23 | 770,833 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award | 2025-05-21 | 2025-05-23 | 89,526 | — | $0 | 770,833 | SEC↗ |
| SLRN ACELYRIN, Inc. | F Tax w/h | 2025-05-15 | 2025-05-19 | 11,039 | $2.17 | $24.0K | 691,565 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award | 2025-05-15 | 2025-05-19 | 30,851 | — | $0 | 702,604 | SEC↗ |
| SLRN ACELYRIN, Inc. | F Tax w/h | 2025-05-15 | 2025-05-19 | 10,258 | $2.17 | $22.3K | 681,307 | SEC↗ |
| SLRN ACELYRIN, Inc. | S Sale | 2025-03-17 | 2025-03-19 | 17,986 | $2.74 | $49.3K | 671,753 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award | 2025-01-23 | 2025-01-24 | 575,000 | — | $0 | 689,739 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2024-05-26 | 2024-05-28 | 1,195,856 | — | $0 | 1,195,856 | SEC↗ |
| SLRN ACELYRIN, Inc. | F Tax w/h | 2024-05-15 | 2024-05-17 | 10,230 | $4.47 | $45.7K | 110,739 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2024-01-09 | 2024-01-11 | 190,114 | — | $0 | 190,114 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award | 2023-08-16 | 2023-08-18 | 114,676 | — | $0 | 119,676 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 85,226 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 362,719 | — | $0 | 362,719 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 362,719 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 85,226 | — | $0 | 85,226 | SEC↗ |
| SLRN ACELYRIN, Inc. | P Buy | 2023-05-09 | 2023-05-11 | 5,000 | $18.00 | $90.0K | 5,000 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2023-05-04 | 2023-05-04 | 85,226 | — | $0 | 85,226 | SEC↗ |
| ZY Zymergen Inc. | S Sale | 2022-09-02 | 2022-09-07 | 3,410 | $2.21 | $7.5K | 298,427 | SEC↗ |
| ZY Zymergen Inc. | S Sale | 2022-08-02 | 2022-08-04 | 3,094 | $2.61 | $8.1K | 301,837 | SEC↗ |
| ZY Zymergen Inc. | S Sale | 2022-07-05 | 2022-07-07 | 2,924 | $1.32 | $3.9K | 304,931 | SEC↗ |
| ZY Zymergen Inc. | S Sale | 2022-06-02 | 2022-06-06 | 2,939 | $1.68 | $4.9K | 307,855 | SEC↗ |
| ZY Zymergen Inc. | S Sale | 2022-05-02 | 2022-05-04 | 3,206 | $1.79 | $5.7K | 310,794 | SEC↗ |
| ZY Zymergen Inc. | A Award | 2022-03-11 | 2022-03-15 | 217,000 | — | $0 | 314,000 | SEC↗ |
| ZY Zymergen Inc. | A Award deriv | 2021-10-26 | 2021-10-28 | 194,000 | — | $0 | 194,000 | SEC↗ |
| ZY Zymergen Inc. | A Award | 2021-10-26 | 2021-10-28 | 97,000 | — | $0 | 97,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | F Tax w/h | 2019-04-09 | 2019-04-10 | 3,674 | $36.85 | $135.4K | 66,389 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-03-26 | 2019-03-27 | 10,000 | — | $0 | 70,063 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 34,125 | — | $0 | 34,125 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-02-06 | 2019-02-08 | 17,063 | — | $0 | 60,063 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2018-04-09 | 2018-04-09 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2018-04-09 | 2018-04-09 | 42,500 | — | $0 | 42,500 | SEC↗ |
| RUN Sunrun Inc. | A Award deriv | 2017-03-15 | 2017-03-17 | 316,000 | — | $0 | 316,000 | SEC↗ |
| RUN Sunrun Inc. | A Award | 2017-03-15 | 2017-03-17 | 131,000 | — | $0 | 327,606 | SEC↗ |
| RUN Sunrun Inc. | A Award | 2016-11-08 | 2016-11-10 | 87,100 | — | $0 | 196,606 | SEC↗ |